---
access_model:
  confidence: medium
  label: Open access
  onboarding: open
  pricing: unknown
  public: true
  source:
  - authentication
  - rate-limits
  - security
  trial: false
  try_now: false
agent_readiness:
  band: agent-aware
  dimensions:
    agent_card: false
    agent_skills: derived
    agentic_access: false
    agentic_commerce: false
    auth_clarity: bearer
    consent_identity: false
    delegated_identity: false
    dry_run_mode: false
    dynamic_client_registration: false
    error_semantics: documented
    event_surface_described: false
    idempotency: false
    mcp_server: false
    openapi_examples: partial
    protected_resource_metadata: false
    rate_limit_signal: documented
    reversibility_documented: false
    spec_presence: true
    well_known_catalog: false
  schema_version: 0.2
  score: 24.3
  scored_at: '2026-09-04'
api_count: 9
apis:
- baseURL: https://matchpointtx.com/wp-json
  baseurl_source: declared
  description: Comment collection. Registered and reachable, but empty — no object on this deployment carries comments.
  name: Matchpoint Therapeutics Comments API
  slug: matchpoint-therapeutics-comments-api
- baseURL: https://matchpointtx.com/wp-json
  baseurl_source: declared
  description: Route, type, taxonomy and status discovery documents.
  name: Matchpoint Therapeutics Discovery API
  slug: matchpoint-therapeutics-discovery-api
- baseURL: https://matchpointtx.com/wp-json
  baseurl_source: declared
  description: Media library — 43 image attachments at harvest time.
  name: Matchpoint Therapeutics Media API
  slug: matchpoint-therapeutics-media-api
- baseURL: https://matchpointtx.com/wp-json
  baseurl_source: declared
  description: oEmbed 1.0 provider endpoint for matchpointtx.com URLs.
  name: Matchpoint Therapeutics Oembed API
  slug: matchpoint-therapeutics-oembed-api
- baseURL: https://matchpointtx.com/wp-json
  baseurl_source: declared
  description: Corporate pages — homepage, privacy policy, terms of use (3 published at harvest time).
  name: Matchpoint Therapeutics Pages API
  slug: matchpoint-therapeutics-pages-api
- baseURL: https://matchpointtx.com/wp-json
  baseurl_source: declared
  description: News archive — company press releases and third-party coverage (5 published at harvest time).
  name: Matchpoint Therapeutics Posts API
  slug: matchpoint-therapeutics-posts-api
- baseURL: https://matchpointtx.com/wp-json
  baseurl_source: declared
  description: Cross-content search across published objects.
  name: Matchpoint Therapeutics Search API
  slug: matchpoint-therapeutics-search-api
- baseURL: https://matchpointtx.com/wp-json
  baseurl_source: declared
  description: Categories, post tags and the team_types taxonomy. Only one category term exists; post_tag and team_types are registered but empty.
  name: Matchpoint Therapeutics Taxonomy API
  slug: matchpoint-therapeutics-taxonomy-api
- baseURL: https://matchpointtx.com/wp-json
  baseurl_source: declared
  description: Leadership, board, observers and scientific founders as a custom post type (19 published at harvest time).
  name: Matchpoint Therapeutics Team API
  slug: matchpoint-therapeutics-team-api
artifact_total: 13
common:
- group: company
  title: ''
  type: Website
  url: https://matchpointtx.com/
- group: company
  title: ''
  type: BlogRSS
  url: https://matchpointtx.com/feed/
- group: company
  title: ''
  type: Careers
  url: https://boards.greenhouse.io/matchpointtx
- group: commercial
  title: ''
  type: PrivacyPolicy
  url: https://matchpointtx.com/privacy-policy/
- group: commercial
  title: ''
  type: TermsOfService
  url: https://matchpointtx.com/terms-conditions/
- group: company
  title: ''
  type: LinkedIn
  url: https://www.linkedin.com/company/matchpoint-therapeutics
- group: company
  title: ''
  type: Twitter
  url: https://twitter.com/matchpointtx
- group: other
  title: ''
  type: SecondaryMarket
  url: https://www.nasdaqprivatemarket.com/company/matchpoint-therapeutics/
- group: other
  title: ''
  type: SecondaryMarket
  url: https://equityzen.com/company/matchpointtherapeutics/
- group: auth
  title: ''
  type: Authentication
  url: authentication/matchpoint-therapeutics-authentication.yml
- group: design
  title: ''
  type: Conventions
  url: conventions/matchpoint-therapeutics-conventions.yml
- group: design
  title: ''
  type: Conformance
  url: conformance/matchpoint-therapeutics-conformance.yml
- group: design
  title: ''
  type: ErrorCatalog
  url: errors/matchpoint-therapeutics-problem-types.yml
- group: design
  title: ''
  type: Lifecycle
  url: lifecycle/matchpoint-therapeutics-lifecycle.yml
- group: design
  title: ''
  type: DataModel
  url: data-model/matchpoint-therapeutics-data-model.yml
- group: other
  title: ''
  type: Overlay
  url: overlays/matchpoint-therapeutics-content-overlay.yaml
- group: auth
  title: ''
  type: DomainSecurity
  url: security/matchpoint-therapeutics-domain-security.yml
- group: build
  title: ''
  type: Packages
  url: packages/matchpoint-therapeutics-packages.yml
- group: commercial
  title: ''
  type: Plans
  url: plans/matchpoint-therapeutics-plans-pricing.yml
- group: operate
  title: ''
  type: RateLimits
  url: rate-limits/matchpoint-therapeutics-rate-limits.yml
- group: agent
  title: ''
  type: LLMsTxt
  url: llms/matchpoint-therapeutics-llms.txt
- group: agent
  title: ''
  type: AgentSkill
  url: skills/_index.yml
created: '2026-08-25'
description: Matchpoint Therapeutics is a privately held biotechnology company headquartered in Watertown, Massachusetts — Cambridge at launch — that discovers precision small-molecule covalent medicines intended to transform the treatment of immune diseases and other serious illness. It was founded by covalent-chemistry, proteomics and computational-science researchers from Stanford University and Harvard Medical School, closed a $30 million seed round co-led by Atlas Venture and Access Biotechnology in November 2021, and launched publicly in October 2022 with $100 million in total financing after a $70 million Series A led by Sanofi Ventures with Vertex Ventures HC, Digitalis Ventures and Alexandria Venture Investments. Its proprietary Advanced Covalent Exploration (ACE) platform combines industry-leading chemoproteomics that detects allosteric, transient and cryptic binding pockets in native cells, machine-learning algorithms that prioritise targets and guide medicinal chemistry, and
  a continuously evolving proprietary library of covalent compounds spanning fragments through drug-like leads. In July 2025 Matchpoint entered an exclusive option and licence agreement with Novartis to develop oral covalent inhibitors against a transcription factor linked to multiple inflammatory diseases, worth up to $60 million upfront and in research funding and up to $1 billion in total potential payments. Matchpoint runs no developer program and publishes no product API, developer portal, API reference or SDK. The only machine-readable surface reachable without credentials is the WordPress REST content API behind matchpointtx.com, catalogued here.
image: https://matchpointtx.com/wp-content/uploads/2022/09/logo-matchpoint.png
layout: provider
modified: '2026-08-25'
name: Matchpoint Therapeutics
nav: Providers
network: true
overview: 'Matchpoint Therapeutics publishes 9 APIs on the [APIs.io](https://apis.io/) network, including Comments API, Discovery API, Media API, and 6 more. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Immunology.


  Matchpoint Therapeutics'' developer surface includes authentication and 21 more developer resources.'
plans:
- name: Matchpoint Therapeutics Plans Pricing
  plan_count: 0
  slug: matchpoint-therapeutics-plans-pricing
random_paper: 6
rate_limits:
- limit_count: 0
  name: Matchpoint Therapeutics Rate Limits
  slug: matchpoint-therapeutics-rate-limits
score:
  band: thin
  composite: 28.0
  coverage:
    artifact_dirs: 18
    catalog_earned: 40.0
    catalog_earned_first_party: 0.0
    catalog_gap: 75.0
    catalog_max: 115.0
    note: 'Disclosure, not a penalty. catalog_gap is rubric points API Evangelist could add with no action by this provider, and it is NOT subtracted from the composite above. It is our backlog EXCEPT where this provider already did the work: catalog_earned is how much of the class was satisfied at all, and catalog_earned_first_party how much of that came from artifacts the provider published rather than ones we generated (roadmap#221). catalog_earned_first_party is a FLOOR, not the whole share: only ~40 of the rubric''s 113 checks carry a provenance class at all, so a check we cannot attribute counts toward neither side. Read it as "at least this much was theirs", never as "the rest was ours".'
  delta: 0.0
  facets:
    access_clarity: 10.5
    commercial_clarity: 10.5
    contract_governance: 4.5
    contract_quality: 53.5
    developer_ergonomics: 13.7
    discoverability: 81.5
    governance: 4.5
    operational_transparency: 0.0
  previous_composite: 28.0
  provenance:
    conformance: derived
    contracts:
      callable: 100.0
      derived: 0
      marker_coverage: 0.0
      total: 9
    mcp: derived
    skills: derived
  regulatory:
    applies: true
    matched_via: tags
    regime: Health
    regime_id: health
    score: 26.3
  schema_version: 0.18.3
  scored_at: '2026-09-04'
  trend: flat
screenshot: https://raw.githubusercontent.com/api-evangelist/matchpoint-therapeutics/refs/heads/main/screenshots/matchpoint-therapeutics-2026-09-02T150436.png
security:
- kind: authentication
  name: Matchpoint Therapeutics Authentication
  slug: matchpoint-therapeutics-authentication
  summary_line: 0 schemes
- kind: domain-security
  name: Matchpoint Therapeutics Domain Security
  slug: matchpoint-therapeutics-domain-security
  summary_line: TLSv1.3 · DMARC
slug: matchpoint-therapeutics
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Immunology
- Covalent Chemistry
- chemoproteomics
- Machine-Learning
- Life Sciences
- content-api
website: https://matchpointtx.com/
---
